Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 113.10
+1.00 (0.89%)
Jan 27, 2026, 1:54 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 103.26 billion as of January 26, 2026. Its market cap has increased by 97.33% in one year.
Market Cap
103.26B
Enterprise Value
100.32B
Revenue
2.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
113.10
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 103.26B, an increase of 456.83%. That is a compound annual growth rate of 34.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 103.26B | -0.80% |
| Dec 31, 2025 | 104.09B | 91.05% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 292.81B |
| WuXi Biologics | 162.53B |
| Innovent Biologics | 145.19B |
| Sino Biopharmaceutical | 118.52B |
| Sichuan Kelun-Biotech Biopharmaceutical | 100.18B |
| 3SBio | 60.84B |
| RemeGen | 58.79B |
| Shanghai Junshi Biosciences | 37.04B |